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Article / Clinical Case Report
ABSTRACT
The finding of a sebaceous carcinoma in a mature teratoma is rare in human pathology, with fewer than 10 cases currently 
reported in the literature. In this article, we report a case of sebaceous carcinoma in a mature teratoma of the ovary in 
a 59-year-old patient and discuss its histological findings. 
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INTRODUCTION
Sebaceous carcinoma in a mature teratoma is 
a rare event of human pathology, with fewer than 
10 cases currently reported in the literature, but none 
from Brazil.1-8
Sebaceous carcinoma is a rare tumor in itself, with 
an incidence of one to two cases per million persons 
a year.9-11 Nonetheless, it is the third most common 
malignancy on the eyelid, after basal cell and squamous 
cell carcinomas. The most common extrapalpebral 
locations are the head and neck, and less frequently 
the trunk and extremities. There are even fewer 
extracutaneous sites, one of which is the ovary.12,13
CASE REPORT
A 59-year-old female patient was admitted to our 
institution for the evaluation of a pelvic mass identified 
on an ultrasound exam. The imaging report described 
an expansive mass on the right adnexa, measuring 
190mm, with both solid and liquid components. 
The patient was submitted to laparotomy with bilateral 
oophorectomy. The procedure was uneventful and 
the patient had a good recovery. The intra-operative 
pathology report identified a teratoma.
After the final histologic report was released, which 
stated malignancy, the patient underwent another 
laparotomy for the removal of the uterus and the omentum; 
peritoneal biopsies were also performed. The pathological 
reports for these organs were unremarkable.
The patient still makes regular follow-up visits to 
our hospital, and almost 3 years later has no further 
complaints and no change in follow-up test results.
PATHOLOGICAL FINDINGS
Grossly, the right ovary showed a smooth and 
uniform external surface, measuring 18.5 × 15.0cm. 
When cut it revealed cysts with an output of greasy 
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material and hair tufts. The inner surface showed a frail 
vegetative yellowish area of 4.5 × 4.0 cm (Figure 1).
Microscopically, the usual components of a 
teratoma were readily identifiable: epidermis, hair 
follicles, and sebaceous glands. Focally, lobular 
arrangements of atypical sebaceous cells – with the 
presence of mitoses and nuclear pleomorphism – 
were observed, constituting a sebaceous carcinoma. 
The malignancy had no capsular nor lymphovascular 
invasion (Figure 2 and 3).
The left uterine adnexa had no gross nor 
microscopic alterations.
DISCUSSION
Teratomas are common neoplasms of the 
human species and can develop in a variety of 
organs. In the ovary, 95% of teratomas are mature 
and cystic – the majority of which are composed of 
differentiated mature tissues and are almost invariably 
benign.14 They are morphologically complex tumors 
containing parts derived from ectoderm (e.g. skin, hair 
follicles, sebaceous glands), mesoderm (e.g. muscles, 
urinary epithelium), and endoderm (e.g. lung and 
gastrointestinal tissue).15 The pathway for developing 
this neoplasm is still uncertain, but studies point to a 
flaw on meiosis II or a pre-meiotic cell with a defective 
meiosis I. These tumors are bilateral in 10%-17% of 
cases.16
The transformation of a mature cystic teratoma 
happens when one or more of its components 
Figure 1. Gross appearance of the specimen after 
fixation and sampling. Note that most of the internal 
surface is lined by a smooth surface and in the center 
of the picture an excrescent and irregular lesion arises, 
which represents the sebaceous carcinoma.
Figure 2. Photomicrographs of the tumor - A – Lobular arrangement of the neoplasm, and absence of capsular 
invasion (H&E, 40X). B – Groups of cells with vacuolated cytoplasm (H&E, 100X).
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becomes malignant, and that occurs in 0.2%-2% of 
cases.17-19 Although all the tissues present in a teratoma 
can go through malignant transformation, more 
than three-quarters of them occur in the squamous 
epithelium, giving rise to a squamous cell carcinoma.
Features that are often seen in association with 
this transformation are: (i) patient age older than 
45 years; (ii) a tumor diameter greater than 10cm; 
(iii) a rapid growth rate; and (iv) imaging findings, 
such as intratumoral low-resistance flux on Doppler 
ultrasound.16,20
H i s t o l o g i c  e v a l u a t i o n  o f  a  s e b a c e o u s 
carcinoma shows malignant cells with various levels 
of differentiation, which are arranged in lobular 
architecture and lined by a fibrovascular stroma. On a 
well-differentiated carcinoma, the cells are vacuolated 
and have a foamy cytoplasm, while in a poorly 
differentiated carcinoma the cells are round with large 
nuclei. Squamous differentiation within a sebaceous 
carcinoma is not a rare finding. Pleomorphic nuclei, 
prominent nucleoli, and mitotic figures can be found.
The immunohistochemistry profile of a sebaceous 
carcinoma is positive for high-molecular-height 
cytokeratin, and epithelial membrane antigen, and 
is negative for low-molecular-height cytokeratin, 
vimentin, and S100.21,22
To date, the treatment for sebaceous carcinoma 
has been surgical with wide excision and margin 
evaluation, with no need for adjuvant or neoadjuvant 
therapy.
The entity in our case – despite its rarity – was 
a clear diagnosis using histological criteria, but it can 
be a propaedeutic challenge. During our literature 
review, we found that different treatments were given 
to patients with this same diagnosis, with different 
outcomes that seemed more related to the extent 
of the disease and to the patients’ underlying health 
conditions.1-8 Our patient had a good response to the 
treatment given, although it could be argued that 
the same outcome could have been achieved without 
the extended surgical approach that followed the 
diagnosis. In conclusion, currently there are not enough 
data to support any particular treatment protocol, 
which means that medical teams need to address each 
new case on an individual basis.
The patient has signed the consent declaration. 
This manuscript has been approved for publication by 
the Research Ethical Committee of Erasto Gaertner 
Hospital.
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